Search clinical trials for: Gaboxadol (HLX-0206)

Total 765 results

Response Pharmaceuticals

Completed

Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension

Hypertension

Germany
Response Pharmaceuticals

Completed

Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension

Hypertension

United Kingdom
Boston Scientific Corporation

Completed

Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology (PINNACLE FLX)

Atrial Fibrillation

United States
Boston Scientific Corporation
Iqvia Pty Ltd; Premier Research Group plc

Completed

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)

Non-valvular Atrial Fibrillation

Ireland, Germany, Denmark, France, Spain, United Kingdom, Italy, Netherlands, Poland
Lorraine Hickson
Bausch Health Americas, Inc.; Solta Medical

Completed

Bausch Health Thermage FXL for Use on Lower Face and Submentum Area

Skin Wrinkling

United States
WideTrial, Inc.

Available

Expanded Access for Treatment Use of PLX-PAD in Critical Limb Ischemia (CLI)

Critical Limb Ischemia (CLI)
Ablynx

Completed

ALX-0061 Phase I Bioavailability Study in Healthy Volunteers

Rheumatoid Arthritis

Netherlands
Ann & Robert H Lurie Children's Hospital of Chicago

Completed

HLA Matching - Unrelated Umbilical Cord Blood Transplantation

Hematologic Diseases

United States
Vaxon Biotech

Completed

Safety Study of Vx006 Vaccine in Solid Tumor Patients

Solid Tumor

Greece
Ovid Therapeutics Inc.

Completed

A Study of OV101 in Individuals With Angelman Syndrome (AS) (NEPTUNE)

Primary Disease or Condition Being Studied: Angelman Syndrome (AS)

United States, Australia, Germany, Israel, Netherlands
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia
Yale University
Hartford HealthCare

Recruiting

The Recovery in Stroke Using PAP Study (RISE-UP)

Ischemic Stroke | Obstructive Sleep Apnea

United States
LogicBio Therapeutics, Inc
Alexion Pharmaceuticals, Inc.

Terminated

Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia (SUNRISE)

Methylmalonic Acidemia

United States
Pluristem Ltd.

Terminated

Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19

COVID | ARDS

Israel, Germany
Erchonia Corporation

Withdrawn

Effect of Erchonia Laser on Erectile Dysfunction

Erectile Dysfunction

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Role of HLA Genes and Innate Immunity in the Phenotypic Variability of COVID-19 (3490)

COVID-19

Italy
Pluristem Ltd.

Completed

Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

Incomplete HCT (Hematopoietic Cell Transplantation)

United States, Israel
Pluristem Ltd.

Completed

Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)

Peripheral Vascular Disease | Peripheral Artery Disease | Critical Limb Ischemia

United States
Beth Israel Deaconess Medical Center

Completed

Duodenoscope Disinfect Study

Endoscopic Retrograde Cholangiopancreatogram (ERCP)
Novo Nordisk A/S

Completed

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis

Inflammation | Rheumatoid Arthritis

Spain, Hungary, Serbia, Bulgaria, Poland, Russian Federation, Latvia
ResoTher Pharma

Recruiting

An Exploratory, Randomised, Double-blind Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)

ST Elevation Myocardial Infarction

Denmark
DermBiont, Inc.
Zepeda Dermatologia

Active, not recruiting

Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis

Seborrheic Keratosis

El Salvador
eTheRNA immunotherapies

Terminated

Safety of Intranodal ECI-006 in Melanoma Patients

Melanoma

Belgium, Spain
CytRx

Withdrawn

INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

United States
Baylor College of Medicine
The Methodist Hospital Research Institute

Recruiting

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. (TETRAVI)

Viral Infection

United States
Pluristem Ltd.

Unknown

Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

Critical Limb Ischemia (CLI)

Germany, United Kingdom, Hungary, United States, Bulgaria, Czechia, Israel, North Macedonia, Poland
Eloxx Pharmaceuticals, Inc.

Terminated

Safety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers

Genetic Diseases | Nonsense Mutations
Ablynx

Completed

An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Spain, Belgium, Bulgaria, Georgia, Germany, Hungary, Mexico, Moldova, Republic of, North Macedonia, Poland, Romania, Serbia
Ablynx

Terminated

First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4

Healthy Volunteers

Netherlands
Takeda

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers

Healthy Volunteers

United States
Boston Scientific Corporation

Active, not recruiting

A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT

The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation

Denmark
Response Pharmaceuticals

Completed

Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides

Hypertriglyceridemia

Germany
Piera Boschetto

Completed

Human Leucocyte Antigen G and Chronic Heart Failure

Chronic Heart Failure

Italy
Ablynx

Completed

Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

Poland, Hungary, Czechia
Flex Pharma, Inc.

Terminated

Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS

Amyotrophic Lateral Sclerosis | Fasciculation

United States
Heron Therapeutics

Completed

A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy

Postoperative Pain

United States
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia

Sweden
H. Lundbeck A/S

Completed

A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

Primary Insomnia
Response Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease

Raynaud's Disease

Germany
Eloxx Pharmaceuticals, Inc.
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ELX-02 in Healthy Adults

Genetic Disease | Nonsense Mutation

Belgium
Veralox Therapeutics

Completed

Phase I Study of VLX-1005 in Healthy Subjects

Safety and Tolerability in Healthy Volunteers

United States
Dart NeuroScience, LLC
Orexo AB

Completed

Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis

Allergic Rhinitis

Sweden
Pluristem Ltd.

Completed

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Intermittent Claudication | Peripheral Artery Disease

United States, Germany, Korea, Republic of, Israel
State-Financed Health Facility "Samara Regional...
INBIO, LLC

Recruiting

Estimation of the Safety and Efficiency Transfusion of HLA Matched CBU in Patients With CP (CP-HLA2019)

Cerebral Palsy

Russian Federation
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia

Sweden
Merck Sharp & Dohme LLC
AstraZeneca

Completed

A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)

Locally Advanced or Metastatic Solid Tumors
Dren Bio
Novotech

Recruiting

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers

Healthy Adult Volunteers

Australia
Huahui Health

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers

Hepatitis B

Australia
Arixa Pharmaceuticals

Unknown

A Single Ascending Dose Study of AV-006 in Healthy Subjects

Bacterial Infections

Australia
Corin

Active, not recruiting

Study to Evaluate Long Term Performance and Safety of the Knee Prosthesis (HLS KneeTec Deep Dish)

Osteo Arthritis Knee | Total Knee Arthroplasty | Total Knee Replacement | Knee Disease

France

Search clinical trials for: Gaboxadol (HLX-0206)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations